List of Tables
Table 1. Global Scopolamine Butylbromide Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Scopolamine Butylbromide Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Scopolamine Butylbromide Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Scopolamine Butylbromide Injection Sales (L) of Key Manufacturers (2020-2025)
Table 5. Global Scopolamine Butylbromide Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Scopolamine Butylbromide Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Scopolamine Butylbromide Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Scopolamine Butylbromide Injection Average Price (US$/mL) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Scopolamine Butylbromide Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Scopolamine Butylbromide Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Scopolamine Butylbromide Injection, Product Type & Application
Table 12. Global Key Manufacturers of Scopolamine Butylbromide Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Scopolamine Butylbromide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Butylbromide Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Scopolamine Butylbromide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Scopolamine Butylbromide Injection Sales by Region (2020-2025) & (L)
Table 18. Global Scopolamine Butylbromide Injection Sales Market Share by Region (2020-2025)
Table 19. Global Scopolamine Butylbromide Injection Sales by Region (2026-2031) & (L)
Table 20. Global Scopolamine Butylbromide Injection Sales Market Share by Region (2026-2031)
Table 21. Global Scopolamine Butylbromide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Scopolamine Butylbromide Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Scopolamine Butylbromide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Scopolamine Butylbromide Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Scopolamine Butylbromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Scopolamine Butylbromide Injection Sales by Country (2020-2025) & (L)
Table 27. North America Scopolamine Butylbromide Injection Sales by Country (2026-2031) & (L)
Table 28. North America Scopolamine Butylbromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Scopolamine Butylbromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Scopolamine Butylbromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Scopolamine Butylbromide Injection Sales by Country (2020-2025) & (L)
Table 32. Europe Scopolamine Butylbromide Injection Sales by Country (2026-2031) & (L)
Table 33. Europe Scopolamine Butylbromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Scopolamine Butylbromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Scopolamine Butylbromide Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Scopolamine Butylbromide Injection Sales by Region (2020-2025) & (L)
Table 37. Asia Pacific Scopolamine Butylbromide Injection Sales by Region (2026-2031) & (L)
Table 38. Asia Pacific Scopolamine Butylbromide Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Scopolamine Butylbromide Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Scopolamine Butylbromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Scopolamine Butylbromide Injection Sales by Country (2020-2025) & (L)
Table 42. Latin America Scopolamine Butylbromide Injection Sales by Country (2026-2031) & (L)
Table 43. Latin America Scopolamine Butylbromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Scopolamine Butylbromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Scopolamine Butylbromide Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Scopolamine Butylbromide Injection Sales by Country (2020-2025) & (L)
Table 47. Middle East and Africa Scopolamine Butylbromide Injection Sales by Country (2026-2031) & (L)
Table 48. Middle East and Africa Scopolamine Butylbromide Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Scopolamine Butylbromide Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Scopolamine Butylbromide Injection Sales (L) by Type (2020-2025)
Table 51. Global Scopolamine Butylbromide Injection Sales (L) by Type (2026-2031)
Table 52. Global Scopolamine Butylbromide Injection Sales Market Share by Type (2020-2025)
Table 53. Global Scopolamine Butylbromide Injection Sales Market Share by Type (2026-2031)
Table 54. Global Scopolamine Butylbromide Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Scopolamine Butylbromide Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Scopolamine Butylbromide Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Scopolamine Butylbromide Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Scopolamine Butylbromide Injection Price (US$/mL) by Type (2020-2025)
Table 59. Global Scopolamine Butylbromide Injection Price (US$/mL) by Type (2026-2031)
Table 60. Global Scopolamine Butylbromide Injection Sales (L) by Application (2020-2025)
Table 61. Global Scopolamine Butylbromide Injection Sales (L) by Application (2026-2031)
Table 62. Global Scopolamine Butylbromide Injection Sales Market Share by Application (2020-2025)
Table 63. Global Scopolamine Butylbromide Injection Sales Market Share by Application (2026-2031)
Table 64. Global Scopolamine Butylbromide Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Scopolamine Butylbromide Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Scopolamine Butylbromide Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Scopolamine Butylbromide Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Scopolamine Butylbromide Injection Price (US$/mL) by Application (2020-2025)
Table 69. Global Scopolamine Butylbromide Injection Price (US$/mL) by Application (2026-2031)
Table 70. AdvaCare Pharma Company Information
Table 71. AdvaCare Pharma Description and Business Overview
Table 72. AdvaCare Pharma Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 73. AdvaCare Pharma Scopolamine Butylbromide Injection Product
Table 74. AdvaCare Pharma Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 78. Boehringer Ingelheim Scopolamine Butylbromide Injection Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 83. Sanofi Scopolamine Butylbromide Injection Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Abbott Laboratories Company Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 88. Abbott Laboratories Scopolamine Butylbromide Injection Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Jiangsu Hengrui Medicine Company Information
Table 91. Jiangsu Hengrui Medicine Description and Business Overview
Table 92. Jiangsu Hengrui Medicine Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 93. Jiangsu Hengrui Medicine Scopolamine Butylbromide Injection Product
Table 94. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 95. Qilu Pharmaceutical Company Information
Table 96. Qilu Pharmaceutical Description and Business Overview
Table 97. Qilu Pharmaceutical Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 98. Qilu Pharmaceutical Scopolamine Butylbromide Injection Product
Table 99. Qilu Pharmaceutical Recent Developments/Updates
Table 100. North China Pharmaceutical Group Company Information
Table 101. North China Pharmaceutical Group Description and Business Overview
Table 102. North China Pharmaceutical Group Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 103. North China Pharmaceutical Group Scopolamine Butylbromide Injection Product
Table 104. North China Pharmaceutical Group Recent Developments/Updates
Table 105. Shanghai Shangyao First Bio-pharmaceutical Company Information
Table 106. Shanghai Shangyao First Bio-pharmaceutical Description and Business Overview
Table 107. Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 108. Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Injection Product
Table 109. Shanghai Shangyao First Bio-pharmaceutical Recent Developments/Updates
Table 110. Sichuan Medco Huakang Pharmaceutical Company Information
Table 111. Sichuan Medco Huakang Pharmaceutical Description and Business Overview
Table 112. Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 113. Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Injection Product
Table 114. Sichuan Medco Huakang Pharmaceutical Recent Developments/Updates
Table 115. AUSMED Company Information
Table 116. AUSMED Description and Business Overview
Table 117. AUSMED Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 118. AUSMED Scopolamine Butylbromide Injection Product
Table 119. AUSMED Recent Developments/Updates
Table 120. Medsurge Healthcare Company Information
Table 121. Medsurge Healthcare Description and Business Overview
Table 122. Medsurge Healthcare Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 123. Medsurge Healthcare Scopolamine Butylbromide Injection Product
Table 124. Medsurge Healthcare Recent Developments/Updates
Table 125. AS Kalceks Company Information
Table 126. AS Kalceks Description and Business Overview
Table 127. AS Kalceks Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 128. AS Kalceks Scopolamine Butylbromide Injection Product
Table 129. AS Kalceks Recent Developments/Updates
Table 130. Pharma Cure Laboratories Company Information
Table 131. Pharma Cure Laboratories Description and Business Overview
Table 132. Pharma Cure Laboratories Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 133. Pharma Cure Laboratories Scopolamine Butylbromide Injection Product
Table 134. Pharma Cure Laboratories Recent Developments/Updates
Table 135. Yabao Pharmaceutical Group Company Information
Table 136. Yabao Pharmaceutical Group Description and Business Overview
Table 137. Yabao Pharmaceutical Group Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 138. Yabao Pharmaceutical Group Scopolamine Butylbromide Injection Product
Table 139. Yabao Pharmaceutical Group Recent Developments/Updates
Table 140. Chengdu First Pharmaceutical Company Information
Table 141. Chengdu First Pharmaceutical Description and Business Overview
Table 142. Chengdu First Pharmaceutical Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 143. Chengdu First Pharmaceutical Scopolamine Butylbromide Injection Product
Table 144. Chengdu First Pharmaceutical Recent Developments/Updates
Table 145. Wepon Company Information
Table 146. Wepon Description and Business Overview
Table 147. Wepon Scopolamine Butylbromide Injection Sales (L), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 148. Wepon Scopolamine Butylbromide Injection Product
Table 149. Wepon Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Scopolamine Butylbromide Injection Distributors List
Table 153. Scopolamine Butylbromide Injection Customers List
Table 154. Scopolamine Butylbromide Injection Market Trends
Table 155. Scopolamine Butylbromide Injection Market Drivers
Table 156. Scopolamine Butylbromide Injection Market Challenges
Table 157. Scopolamine Butylbromide Injection Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Scopolamine Butylbromide Injection
Figure 2. Global Scopolamine Butylbromide Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Scopolamine Butylbromide Injection Market Share by Type: 2024 & 2031
Figure 4. 1ml:20mg Product Picture
Figure 5. 2ml:40mg Product Picture
Figure 6. Global Scopolamine Butylbromide Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Scopolamine Butylbromide Injection Market Share by Application: 2024 & 2031
Figure 8. Urinary Tract Spasm
Figure 9. Biliary Tract Spasm
Figure 10. Gastrointestinal Spasm
Figure 11. Global Scopolamine Butylbromide Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Scopolamine Butylbromide Injection Market Size (2020-2031) & (US$ Million)
Figure 13. Global Scopolamine Butylbromide Injection Sales (2020-2031) & (L)
Figure 14. Global Scopolamine Butylbromide Injection Average Price (US$/mL) & (2020-2031)
Figure 15. Scopolamine Butylbromide Injection Report Years Considered
Figure 16. Scopolamine Butylbromide Injection Sales Share by Manufacturers in 2024
Figure 17. Global Scopolamine Butylbromide Injection Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Scopolamine Butylbromide Injection Players: Market Share by Revenue in Scopolamine Butylbromide Injection in 2024
Figure 19. Scopolamine Butylbromide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Scopolamine Butylbromide Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Scopolamine Butylbromide Injection Sales Market Share by Country (2020-2031)
Figure 22. North America Scopolamine Butylbromide Injection Revenue Market Share by Country (2020-2031)
Figure 23. United States Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Scopolamine Butylbromide Injection Sales Market Share by Country (2020-2031)
Figure 26. Europe Scopolamine Butylbromide Injection Revenue Market Share by Country (2020-2031)
Figure 27. Germany Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Scopolamine Butylbromide Injection Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Scopolamine Butylbromide Injection Revenue Market Share by Region (2020-2031)
Figure 34. China Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Scopolamine Butylbromide Injection Sales Market Share by Country (2020-2031)
Figure 42. Latin America Scopolamine Butylbromide Injection Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Scopolamine Butylbromide Injection Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Scopolamine Butylbromide Injection Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Scopolamine Butylbromide Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Scopolamine Butylbromide Injection by Type (2020-2031)
Figure 53. Global Revenue Market Share of Scopolamine Butylbromide Injection by Type (2020-2031)
Figure 54. Global Scopolamine Butylbromide Injection Price (US$/mL) by Type (2020-2031)
Figure 55. Global Sales Market Share of Scopolamine Butylbromide Injection by Application (2020-2031)
Figure 56. Global Revenue Market Share of Scopolamine Butylbromide Injection by Application (2020-2031)
Figure 57. Global Scopolamine Butylbromide Injection Price (US$/mL) by Application (2020-2031)
Figure 58. Scopolamine Butylbromide Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
